Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?
Activation of common signaling pathways during remodeling of the heart and the bladder
Regulation of human (adrenal) androgen biosynthesis—New insights from novel throughput technology studies
Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells
Cucurbitacin I elicits the formation of actin/phospho-myosin II co-aggregates by stimulation of the RhoA/ROCK pathway and inhibition of LIM-kinase
Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule
Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells
The morphogenetically active polymer, inorganic polyphosphate complexed with GdCl3, as an inducer of hydroxyapatite formation in vitro
Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells
Serum- and glucocorticoid-inducible kinase SGK2 regulates human organic anion transporters 4 via ubiquitin ligase Nedd4-2
The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases
Retraction notice to “Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway” [Biochem. Pharmacol. 82 (2011) 1134–1144],
Retraction notice to “Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake” [Biochem. Pharmacol. 80 (2010) 1021–1032],
Retraction notice to “Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo ” [Biochem. Pharmacol. 79 (2010) 330–338],
Retraction notice to “Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: Role of Michael acceptors and Michael donors” [Biochem. Pharmacol. 82 (2011) 1901–1909],
Retraction notice to “Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers” [Biochem. Pharmacol. 79 (2010) 218–228],
Retraction notice to “Thymoquinone poly(lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential” [Biochem. Pharmacol. 79 (2010) 1640–1647],
Retraction notice to “Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines” [Biochem. Pharmacol. 73 (2007) 1024–1032],